Conglomerates
Compare Stocks
5 / 10Stock Comparison
MMM vs CAT vs HON vs EMR vs ETN
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Conglomerates
Industrial - Machinery
Industrial - Machinery
MMM vs CAT vs HON vs EMR vs ETN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Conglomerates | Agricultural - Machinery | Conglomerates | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $74.98B | $416.75B | $136.91B | $79.02B | $155.02B |
| Revenue (TTM) | $25.02B | $70.75B | $36.76B | $18.32B | $28.52B |
| Net Income (TTM) | $2.79B | $9.42B | $4.10B | $2.44B | $3.99B |
| Gross Margin | 39.5% | 32.5% | 36.9% | 52.7% | 36.9% |
| Operating Margin | 19.6% | 16.6% | 14.9% | 19.8% | 18.1% |
| Forward P/E | 16.6x | 38.8x | 20.5x | 21.7x | 30.0x |
| Total Debt | $12.94B | $43.33B | $34.58B | $13.76B | $11.17B |
| Cash & Equiv. | $5.24B | $9.98B | $12.49B | $1.54B | $622M |
MMM vs CAT vs HON vs EMR vs ETN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| 3M Company (MMM) | 100 | 109.9 | +9.9% |
| Caterpillar Inc. (CAT) | 100 | 745.6 | +645.6% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Eaton Corporation p… (ETN) | 100 | 470.2 | +370.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MMM vs CAT vs HON vs EMR vs ETN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MMM is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.06, current ratio 1.71x
- Beta 1.06, yield 1.5%, current ratio 1.71x
- Lower P/E (16.6x vs 21.7x)
CAT has the current edge in this matchup, primarily because of its strength in long-term compounding.
- 12.3% 10Y total return vs ETN's 6.1%
- +181.5% vs HON's +2.8%
- 10.0% ROA vs HON's 5.3%, ROIC 15.9% vs 12.6%
HON is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Beta 0.74 vs CAT's 1.54
- 2.1% yield, 15-year raise streak, vs EMR's 1.5%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
ETN ranks third and is worth considering specifically for growth exposure and valuation efficiency.
- Rev growth 10.3%, EPS growth 10.1%, 3Y rev CAGR 9.8%
- PEG 1.22 vs HON's 11.18
- 10.3% revenue growth vs MMM's 1.5%
- 14.0% margin vs MMM's 11.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.3% revenue growth vs MMM's 1.5% | |
| Value | Lower P/E (16.6x vs 21.7x) | |
| Quality / Margins | 14.0% margin vs MMM's 11.1% | |
| Stability / Safety | Beta 0.74 vs CAT's 1.54 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +181.5% vs HON's +2.8% | |
| Efficiency (ROA) | 10.0% ROA vs HON's 5.3%, ROIC 15.9% vs 12.6% |
MMM vs CAT vs HON vs EMR vs ETN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MMM vs CAT vs HON vs EMR vs ETN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 1 of 6 categories
MMM leads 1 • CAT leads 1 • HON leads 0 • ETN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CAT is the larger business by revenue, generating $70.8B annually — 3.9x EMR's $18.3B. Profitability is closely matched — net margins range from 14.0% (ETN) to 11.1% (MMM). On growth, CAT holds the edge at +22.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $25.0B | $70.8B | $36.8B | $18.3B | $28.5B |
| EBITDAEarnings before interest/tax | $5.2B | $14.0B | $6.5B | $4.7B | $5.9B |
| Net IncomeAfter-tax profit | $2.8B | $9.4B | $4.1B | $2.4B | $4.0B |
| Free Cash FlowCash after capex | $2.1B | $11.4B | $4.2B | $3.1B | $4.7B |
| Gross MarginGross profit ÷ Revenue | +39.5% | +32.5% | +36.9% | +52.7% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +19.6% | +16.6% | +14.9% | +19.8% | +18.1% |
| Net MarginNet income ÷ Revenue | +11.1% | +13.3% | +11.2% | +13.3% | +14.0% |
| FCF MarginFCF ÷ Revenue | +8.2% | +16.2% | +11.4% | +17.0% | +16.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.3% | +22.2% | -6.9% | +2.9% | +16.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -39.7% | +30.2% | -41.9% | +28.2% | -9.4% |
Valuation Metrics
MMM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 24.0x trailing earnings, MMM trades at a 50% valuation discount to CAT's 47.6x P/E. Adjusting for growth (PEG ratio), ETN offers better value at 1.55x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $75.0B | $416.8B | $136.9B | $79.0B | $155.0B |
| Enterprise ValueMkt cap + debt − cash | $82.7B | $450.1B | $159.0B | $91.2B | $165.6B |
| Trailing P/EPrice ÷ TTM EPS | 23.96x | 47.57x | 29.36x | 34.92x | 38.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.55x | 38.79x | 20.52x | 21.71x | 30.00x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.69x | 15.99x | 7.73x | 1.55x |
| EV / EBITDAEnterprise value multiple | 15.20x | 33.41x | 19.99x | 18.07x | 27.69x |
| Price / SalesMarket cap ÷ Revenue | 3.01x | 6.17x | 3.66x | 4.39x | 5.65x |
| Price / BookPrice ÷ Book value/share | 16.32x | 19.71x | 9.00x | 3.94x | 7.99x |
| Price / FCFMarket cap ÷ FCF | 53.71x | 40.56x | 25.39x | 29.63x | 34.67x |
Profitability & Efficiency
Evenly matched — MMM and ETN each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
MMM delivers a 65.3% return on equity — every $100 of shareholder capital generates $65 in annual profit, vs $12 for EMR. ETN carries lower financial leverage with a 0.57x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMM's 2.73x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs CAT's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +65.3% | +47.5% | +23.1% | +12.1% | +20.8% |
| ROA (TTM)Return on assets | +7.5% | +10.0% | +5.3% | +5.8% | +9.0% |
| ROICReturn on invested capital | +28.1% | +15.9% | +12.6% | +8.2% | +13.6% |
| ROCEReturn on capital employed | +16.1% | +19.1% | +12.6% | +10.0% | +16.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 2.73x | 2.03x | 2.24x | 0.68x | 0.57x |
| Net DebtTotal debt minus cash | $7.7B | $33.4B | $22.1B | $12.2B | $10.5B |
| Cash & Equiv.Liquid assets | $5.2B | $10.0B | $12.5B | $1.5B | $622M |
| Total DebtShort + long-term debt | $12.9B | $43.3B | $34.6B | $13.8B | $11.2B |
| Interest CoverageEBIT ÷ Interest expense | 6.52x | 9.22x | 3.92x | 6.46x | 16.38x |
Total Returns (Dividends Reinvested)
CAT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAT five years ago would be worth $38,251 today (with dividends reinvested), compared to $9,690 for MMM. Over the past 12 months, CAT leads with a +181.5% total return vs HON's +2.8%. The 3-year compound annual growth rate (CAGR) favors CAT at 62.0% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -10.7% | +50.2% | +10.9% | +4.3% | +22.3% |
| 1-Year ReturnPast 12 months | +5.8% | +181.5% | +2.8% | +30.4% | +33.2% |
| 3-Year ReturnCumulative with dividends | +80.7% | +324.9% | +16.2% | +75.9% | +141.3% |
| 5-Year ReturnCumulative with dividends | -3.1% | +282.5% | +3.3% | +59.5% | +182.8% |
| 10-Year ReturnCumulative with dividends | +32.5% | +1227.6% | +135.1% | +206.6% | +608.7% |
| CAGR (3Y)Annualised 3-year return | +21.8% | +62.0% | +5.1% | +20.7% | +34.1% |
Risk & Volatility
Evenly matched — CAT and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than CAT's 1.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAT currently trades 96.2% from its 52-week high vs MMM's 81.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.06x | 1.54x | 0.74x | 1.52x | 1.42x |
| 52-Week HighHighest price in past year | $177.41 | $931.35 | $248.18 | $165.15 | $435.43 |
| 52-Week LowLowest price in past year | $137.70 | $318.11 | $186.76 | $108.37 | $296.93 |
| % of 52W HighCurrent price vs 52-week peak | +81.0% | +96.2% | +87.1% | +85.4% | +91.7% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 76.2 | 45.1 | 61.3 | 59.8 |
| Avg Volume (50D)Average daily shares traded | 3.6M | 2.4M | 3.7M | 2.8M | 2.5M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MMM as "Hold", CAT as "Buy", HON as "Buy", EMR as "Buy", ETN as "Buy". Consensus price targets imply 16.0% upside for MMM (target: $167) vs -7.9% for CAT (target: $825). For income investors, HON offers the higher dividend yield at 2.14% vs CAT's 0.65%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $166.75 | $824.80 | $243.83 | $161.92 | $379.78 |
| # AnalystsCovering analysts | 33 | 53 | 28 | 41 | 39 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +0.7% | +2.1% | +1.5% | +1.0% |
| Dividend StreakConsecutive years of raises | 0 | 8 | 15 | 37 | 24 |
| Dividend / ShareAnnual DPS | $2.18 | $5.86 | $4.63 | $2.10 | $4.17 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.4% | +1.2% | +2.8% | +1.6% | +1.2% |
EMR leads in 1 of 6 categories (Income & Cash Flow). MMM leads in 1 (Valuation Metrics). 3 tied.
MMM vs CAT vs HON vs EMR vs ETN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MMM or CAT or HON or EMR or ETN a better buy right now?
For growth investors, Eaton Corporation plc (ETN) is the stronger pick with 10.
3% revenue growth year-over-year, versus 1. 5% for 3M Company (MMM). 3M Company (MMM) offers the better valuation at 24. 0x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Caterpillar Inc. (CAT) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MMM or CAT or HON or EMR or ETN?
On trailing P/E, 3M Company (MMM) is the cheapest at 24.
0x versus Caterpillar Inc. at 47. 6x. On forward P/E, 3M Company is actually cheaper at 16. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Eaton Corporation plc wins at 1. 22x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — MMM or CAT or HON or EMR or ETN?
Over the past 5 years, Caterpillar Inc.
(CAT) delivered a total return of +282. 5%, compared to -3. 1% for 3M Company (MMM). Over 10 years, the gap is even starker: CAT returned +1228% versus MMM's +32. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MMM or CAT or HON or EMR or ETN?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Caterpillar Inc. 's 1. 54β — meaning CAT is approximately 108% more volatile than HON relative to the S&P 500. On balance sheet safety, Eaton Corporation plc (ETN) carries a lower debt/equity ratio of 57% versus 3% for 3M Company — giving it more financial flexibility in a downturn.
05Which is growing faster — MMM or CAT or HON or EMR or ETN?
By revenue growth (latest reported year), Eaton Corporation plc (ETN) is pulling ahead at 10.
3% versus 1. 5% for 3M Company (MMM). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -20. 5% for 3M Company. Over a 3-year CAGR, ETN leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MMM or CAT or HON or EMR or ETN?
Eaton Corporation plc (ETN) is the more profitable company, earning 14.
9% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 16. 6% for CAT. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MMM or CAT or HON or EMR or ETN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Eaton Corporation plc (ETN) is the more undervalued stock at a PEG of 1. 22x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, 3M Company (MMM) trades at 16. 6x forward P/E versus 38. 8x for Caterpillar Inc. — 22. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMM: 16. 0% to $166. 75.
08Which pays a better dividend — MMM or CAT or HON or EMR or ETN?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 7% for Caterpillar Inc. (CAT).
09Is MMM or CAT or HON or EMR or ETN better for a retirement portfolio?
For long-horizon retirement investors, Caterpillar Inc.
(CAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 7% yield, +1228% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CAT: +1228%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MMM and CAT and HON and EMR and ETN?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.